Nursing Elites

1. A nurse receives a prescription for an antibiotic for a client with cellulitis. The nurse checks the client’s medical record, discovers the client's allergy to the antibiotic, and calls the provider for a different prescription. Which of the following critical thinking attitudes did the nurse demonstrate?

• A. Fairness
• B. Responsibility
• C. Risk-taking
• D. Creativity

Correct answer: B

Rationale: The nurse demonstrated responsibility by recognizing the potential harm of administering an antibiotic the client is allergic to and taking the necessary steps to ensure the client's safety. Choice A, 'Fairness,' is not applicable in this scenario as it does not involve treating individuals equitably. Choice C, 'Risk-taking,' is incorrect as the nurse's actions aimed to minimize risks rather than taking them. Choice D, 'Creativity,' is not the best fit as the nurse's actions focused on following established protocols and ensuring patient safety rather than thinking innovatively.

2. When reviewing a client’s fluid and electrolyte status, what should the nurse report to the provider?

• A. Potassium 5.4
• B. Sodium 140
• C. Calcium 8.6
• D. Magnesium 2.0

Correct answer: A

Rationale: The correct answer is A: 'Potassium 5.4'. A potassium level of 5.4 is elevated (normal range is typically 3.5-5.0 mEq/L) and may indicate hyperkalemia, which can have serious cardiac implications. Elevated potassium levels can lead to life-threatening arrhythmias, so immediate reporting and intervention are necessary. Choice B, 'Sodium 140', falls within the normal range (135-145 mEq/L) and does not require immediate reporting. Choice C, 'Calcium 8.6', falls within the normal range (8.5-10.5 mg/dL) and is not an immediate concern. Choice D, 'Magnesium 2.0', is within the normal range (1.5-2.5 mEq/L) and does not need urgent reporting. Therefore, the nurse should prioritize reporting the elevated potassium level as it poses the most immediate risk.

3. A client with diabetes mellitus reports feeling anxious, shaky, and weak. These findings are manifestations of which of the following complications?

• A. Hyperglycemia
• B. Hypoglycemia
• C. Ketoacidosis
• D. Dawn phenomenon

Correct answer: B

Rationale: The correct answer is B, Hypoglycemia. In diabetes mellitus, hypoglycemia can lead to symptoms such as anxiety, shakiness, and weakness due to low blood sugar levels. Hyperglycemia (choice A) is high blood sugar levels and typically presents with symptoms like increased thirst and frequent urination. Ketoacidosis (choice C) is a serious complication of diabetes characterized by high levels of ketones in the blood, leading to symptoms such as fruity breath and rapid breathing. The Dawn phenomenon (choice D) refers to an abnormal early-morning increase in blood sugar levels without an associated hypoglycemia during the night.

4. A client who is 3 days post-op following a cholecystectomy has yellow and thick drainage on the dressing. The nurse suspects a wound infection. The nurse identifies this type of drainage as:

• A. Purulent
• B. Serous
• C. Sanguineous
• D. Serosanguineous

Correct answer: A

Rationale: The correct answer is A: Purulent. Purulent drainage is thick, yellow, and indicates the presence of infection. This type of drainage is typically seen in infected wounds. Choice B, Serous drainage, is thin, clear, and watery, which is normal in the initial stages of wound healing. Sanguineous drainage, choice C, is bright red and indicates fresh bleeding. Serosanguineous drainage, choice D, is pale pink to red and is a mixture of blood and serous fluid commonly seen in the early stages of wound healing.

5. A client with chronic kidney disease is receiving epoetin alfa (Epogen). Which laboratory value should the LPN/LVN monitor to determine the effectiveness of this medication?

• A. Serum potassium
• B. Hemoglobin
• C. Serum creatinine
• D. Blood urea nitrogen (BUN)

Correct answer: B

Rationale: The correct answer is B: Hemoglobin. Monitoring hemoglobin levels is essential to assess the effectiveness of epoetin alfa in clients with chronic kidney disease. Epoetin alfa is a medication that stimulates red blood cell production, aiming to increase hemoglobin levels and improve symptoms of anemia in these patients. Monitoring serum potassium (Choice A) is important in clients with kidney disease, but it is more related to assessing electrolyte balance rather than the direct effectiveness of epoetin alfa. Serum creatinine (Choice C) and blood urea nitrogen (Choice D) are kidney function tests that help evaluate kidney health but do not specifically reflect the effectiveness of epoetin alfa therapy.

Similar Questions